Suppr超能文献

促性腺激素释放激素类似物抑制青春期时的肾上腺功能初现和骨骼成熟。

Adrenarche and skeletal maturation during luteinizing hormone releasing hormone analogue suppression of gonadarche.

作者信息

Wierman M E, Beardsworth D E, Crawford J D, Crigler J F, Mansfield M J, Bode H H, Boepple P A, Kushner D C, Crowley W F

出版信息

J Clin Invest. 1986 Jan;77(1):121-6. doi: 10.1172/JCI112265.

Abstract

During puberty the effects of adrenal androgens upon skeletal maturation are obscured by the influence of gonadal steroids. Suppression of gonadarche with an analogue of luteinizing hormone releasing hormone (LHRHa) affords an opportunity to examine the onset and progression of adrenarche in the absence of pubertal levels of gonadal steroids in a controlled fashion and to explore the relationship between adrenal androgens and the rate of epiphyseal maturation. In 29 children with central precocious puberty, gonadarche was suppressed with LHRHa administration for 1-4 yr. During LHRHa exposure, dehydroepiandrosterone sulfate (DHAS) levels, as an index of adrenal maturation, were constant or increased in an age-expected manner. The change in bone age for change in chronologic age decreased from 1.7 +/- 0.1 to 0.49 +/- 0.05 (P = 0.00005), indicating that the LHRHa-induced return to a prepubertal gonadal steroid environment was associated with a slowing of skeletal maturation. DHAS levels were correlated with the rate of skeletal advancement before (r = 0.57, P = 0.001) and during 12 to 48 mo of exposure to LHRHa (r = 0.52, P = 0.003). A negative correlation of DHAS values with subsequent increases in predicted mature height was observed (r = -0.49, P = 0.007). Thus, in children with central precocious puberty, adrenarche progressed normally during LHRHa suppression of gonadarche. In children with the onset of progression of adrenarche during maintenance of a prepubertal gonadal steroid milieu, there was less evidence than in preadrenarchal children of a restraint upon skeletal maturation. These data suggest that adrenal androgens contribute importantly to epiphyseal advancement during childhood.

摘要

在青春期,性腺类固醇的影响会掩盖肾上腺雄激素对骨骼成熟的作用。使用促黄体生成素释放激素类似物(LHRHa)抑制性腺发育,为在可控方式下,在没有青春期水平的性腺类固醇的情况下,研究肾上腺发育的起始和进展,以及探索肾上腺雄激素与骨骺成熟速率之间的关系提供了机会。在29例中枢性性早熟儿童中,通过给予LHRHa抑制性腺发育1至4年。在LHRHa治疗期间,硫酸脱氢表雄酮(DHAS)水平作为肾上腺成熟的指标,以与年龄相符的方式保持稳定或升高。骨龄变化与实际年龄变化的比值从1.7±0.1降至0.49±0.05(P = 0.00005),表明LHRHa诱导的回到青春期前性腺类固醇环境与骨骼成熟减缓有关。在LHRHa治疗前(r = 0.57,P = 0.001)以及治疗12至48个月期间(r = 0.52,P = 0.003),DHAS水平与骨骼发育速率相关。观察到DHAS值与随后预测的成熟身高增加呈负相关(r = -0.49,P = 0.007)。因此,在中枢性性早熟儿童中,在LHRHa抑制性腺发育期间,肾上腺发育正常进行。在青春期前性腺类固醇环境维持期间肾上腺发育开始或进展的儿童中,与青春期前儿童相比,骨骼成熟受抑制的证据较少。这些数据表明,肾上腺雄激素在儿童期对骨骺发育有重要贡献。

相似文献

引用本文的文献

3
Non-PCOS Hyperandrogenic Disorders in Adolescents.青少年非多囊卵巢综合征性高雄激素血症。
Semin Reprod Med. 2022 Mar;40(1-02):42-52. doi: 10.1055/s-0041-1742259. Epub 2022 Jan 20.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验